Nagarro SE (0AA3)
London Exchange · UK · prices in EUR · close of 21 Oct 2026
Key indicators
| Last close | EUR 78.85 |
|---|---|
| 52-week range | 32.21 – 80.60 |
| Return, 1 month / 3 months | −0.4% / +3.6% |
| Return, 1 year / 3 years | +59.3% / +18.2% |
| Trend | Uptrend |
| RSI (14) | 53 |
| Volatility (1 year) | 81.0% |
| Worst drawdown (1 year) | -58.3% |
| Average daily value traded | 0.61M EUR |
| Dividend yield | 1.3% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Nagarro SE is a digital engineering and technology services company based in Munich, Germany. It helps clients design, build and run software, offering services such as digital product engineering, software development, enterprise resource planning support, data and analytics, and cloud and automation work. Its customers are businesses and organisations across sectors including automotive, banking, insurance, manufacturing, retail and travel, served through teams in many countries.
The shares are listed on the London Exchange in UK under the code 0AA3, and the price on this page is in euros (EUR). Our dividend records, which start in 2019, show payments in 2 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Nagarro SE (0AA3) trades on the London Exchange in UK. It last closed at EUR 78.85 on 21 October 2026.
Its price-based Market X-Ray is 57 out of 100 (a fair price profile), ranking 1,596 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 59.3% and over the last three months it rose 3.6%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 94 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 28.8% | ||
| From 52-week high | -0.8% | ||
| Momentum | 83 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 3.6% | ||
| 6-month return | 80.4% | ||
| 12-month return, skipping the last month | 60.0% | ||
| Stability (higher is calmer) | 12 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 81.0% | ||
| Worst drawdown, 1 year (smaller is calmer) | -58.3% | ||
| Liquidity | 47 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.61M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 27 · Weak | Dividend is small or irregular. | |
| Dividend yield | 1.3% | ||
| Years with dividends | 2 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
- Income: Dividend is small or irregular.
Returns
| 1 week | −0.1% |
|---|---|
| 1 month | −0.4% |
| 3 months | +3.6% |
| 6 months | +80.4% |
| 1 year | +59.3% |
| 3 years | +18.2% |
| 5 years | −53.5% |
Signals
| 50-day / 200-day average | 78.49 / 61.20 |
|---|---|
| Golden / death cross (60 days) | Golden, 57 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.88 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 30 Jun 2026 | EUR 1.0000 |
| 1 Jul 2025 | EUR 1.0000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.